Physician profile
Tian Wang
NPI 1174044507
$2,017.03
in general payments reported to CMS, 2019-2025
21 companies · $428 in 2025
The $428 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $17.75 · 2022: $29.61 · 2023: $508 · 2024: $1,034 · 2025: $428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,953 · Education: $16.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,952.95 |
| Education | $16.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $485.78 | 2022-2025 | Botox, Qulipta, Ubrelvy |
| Sk Life Science, INC. | $260.25 | 2023-2025 | |
| Lilly USA, LLC | $207.88 | 2023-2025 | Amyvid, Kisunla, Reyvow |
| Ucb, INC. | $160.80 | 2023-2025 | Briviact |
| Eisai INC. | $147.18 | 2023-2024 | |
| Amgen INC. | $133.96 | 2024-2025 | Uplizna |
| Jazz Pharmaceuticals INC. | $130.46 | 2024 | |
| Amneal Pharmaceuticals LLC | $82.17 | 2023-2024 | Rytary, Ongentys 50mg Capsules 30 |
| Pfizer INC. | $51.43 | 2024 | |
| Acadia Pharmaceuticals INC | $49.41 | 2023-2025 | Nuplazid, Daybue |
| Neurelis, INC. | $48.40 | 2023-2024 | Valtoco |
| Catalyst Pharmaceuticals, INC. | $47.59 | 2023-2024 | Fycompa |
| Biogen, INC. | $42.64 | 2024-2025 | Vumerity, Plegridy, Tysabri |
| Axsome Therapeutics, INC. | $32.39 | 2025 | Symbravo |
| Livanova USA, INC. | $29.11 | 2025 | Vns Therapy Sentiva Model 1000 Generator |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $22.99 | 2024 | Vyepti |
| Genentech USA, INC. | $19.77 | 2024 | Ocrevus |
| Genzyme Corporation | $19.01 | 2025 | |
| Acorda Therapeutics, INC | $17.75 | 2020 | |
| Banner Life Sciences, LLC | $14.36 | 2024 | |
| Medtronic, INC. | $13.70 | 2023 | Percept PC Brainsense |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tian Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.